Results for “ ”

Entry Author Date Location
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device 02/19/20 Boston
Xcelerating Life Sciences Boston Will Explore Biopharma’s Future in Digital Health 02/19/20 Boston
ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise 02/19/20 Boston
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff 02/10/20 Boston
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More 02/07/20 National
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D 01/30/20 Boston
Vizgen Launches With $14M to Market New Subcellular Imaging Technique 01/30/20 Boston
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus 01/29/20 Boston
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family 01/27/20 Boston
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Page 2 of 379 « previous page · next page »